West Pharmaceutical Services Inc. buy Citigroup Inc.
Start price
08.01.25
/
50%
€326.40
Target price
08.01.26
€388.28
Performance (%)
-28.37%
End price
09.01.26
€233.80
Summary
This prediction ended on 09.01.26 with a price of €233.80. The prediction for West Pharmaceutical Services Inc. disappointed with a performance of -28.37%. Citigroup_Inc_ has a follow-up prediction for West Pharmaceutical Services Inc. where he still thinks West Pharmaceutical Services Inc. is a Buy. A total of €0.20 was paid as dividends for this prediction. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| West Pharmaceutical Services Inc. | 1.636% | 1.636% | 47.451% |
| iShares Core DAX® | -1.862% | 0.670% | 0.920% |
| iShares Nasdaq 100 | -3.322% | 4.989% | 33.716% |
| iShares Nikkei 225® | -2.299% | 6.129% | 52.955% |
| iShares S&P 500 | -1.313% | 3.399% | 24.674% |
Comments by Citigroup_Inc_ for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $400.00 price target on the stock.
Ratings data for WST provided by MarketBeat
In the thread Trading West Pharmaceutical Services Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€258.60
24.04.26
24.04.26
-
24.04.27
24.04.27
5.68%
04.06.26
04.06.26
